AXERT Drug Patent Profile
✉ Email this page to a colleague
When do Axert patents expire, and what generic alternatives are available?
Axert is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in AXERT is almotriptan malate. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Axert
A generic version of AXERT was approved as almotriptan malate by TEVA PHARMS USA on July 7th, 2015.
Summary for AXERT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 395 |
Drug Prices: | Drug price information for AXERT |
What excipients (inactive ingredients) are in AXERT? | AXERT excipients list |
DailyMed Link: | AXERT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AXERT
Paragraph IV (Patent) Challenges for AXERT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AXERT | Tablets | almotriptan malate | 6.25 mg and 12.5 mg | 021001 | 1 | 2005-12-08 |
US Patents and Regulatory Information for AXERT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-001 | May 7, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-002 | May 7, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AXERT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-001 | May 7, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-002 | May 7, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AXERT
See the table below for patents covering AXERT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 10199016 | ⤷ Try a Trial | |
South Korea | 100191830 | ⤷ Try a Trial | |
New Zealand | 254152 | NITROGEN RING SUBSTITUTED SULPHONYL INDOLE DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS THEREOF | ⤷ Try a Trial |
Finland | 941413 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AXERT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0605697 | 2001 00005 | Denmark | ⤷ Try a Trial | DKCTFF CA 2001 00005, 20010226, EXPIRES: 20150329 |
0605697 | SPC003/2001 | Ireland | ⤷ Try a Trial | SPC003/2001: 20041230, EXPIRES: 20141222 |
0605697 | C00605697/01 | Switzerland | ⤷ Try a Trial | FORMER OWNER: LABORATORIOS ALMIRALL, S.A., ES |
0605697 | C300053 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ALMOTRIPTAN DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH GESCHIKT ZOUT, IN HET BIJZONDER HET WATERSTOFMALAAT; REGISTRATION NO/DATE: RVG 25415 - RVG 25416 20010309 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |